CINECA IRIS Institutional Research Information System

ROMAGNOLO, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.755
EU - Europa 1.934
AS - Asia 1.228
SA - Sud America 74
OC - Oceania 32
AF - Africa 22
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.047
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.691
IT - Italia 550
CN - Cina 503
SG - Singapore 332
IE - Irlanda 281
SE - Svezia 257
FR - Francia 143
DE - Germania 139
JP - Giappone 113
AT - Austria 111
GB - Regno Unito 86
IN - India 60
FI - Finlandia 59
CA - Canada 54
BR - Brasile 53
ES - Italia 53
VN - Vietnam 49
KR - Corea 42
PL - Polonia 38
UA - Ucraina 38
BE - Belgio 34
NL - Olanda 31
AU - Australia 28
HK - Hong Kong 28
TR - Turchia 28
ID - Indonesia 24
CH - Svizzera 17
PT - Portogallo 17
GR - Grecia 16
RO - Romania 16
TW - Taiwan 14
CZ - Repubblica Ceca 10
MX - Messico 10
AR - Argentina 9
RU - Federazione Russa 9
CO - Colombia 6
IR - Iran 6
SN - Senegal 6
UZ - Uzbekistan 6
BG - Bulgaria 5
EG - Egitto 5
PH - Filippine 5
SI - Slovenia 5
CL - Cile 4
DK - Danimarca 4
MY - Malesia 4
NZ - Nuova Zelanda 4
CY - Cipro 3
HR - Croazia 3
IL - Israele 3
TH - Thailandia 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CM - Camerun 2
HU - Ungheria 2
MA - Marocco 2
MT - Malta 2
RS - Serbia 2
A1 - Anonimo 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
EC - Ecuador 1
EE - Estonia 1
EU - Europa 1
GH - Ghana 1
IS - Islanda 1
KW - Kuwait 1
MD - Moldavia 1
OM - Oman 1
PE - Perù 1
ZA - Sudafrica 1
Totale 7.047
Salva come PNG Salva come JPEG
Città #
Chandler 629
Dublin 279
Singapore 270
Beijing 227
Ann Arbor 191
Torino 188
Ashburn 183
Fairfield 172
Santa Clara 156
Houston 116
Nyköping 116
Vienna 104
Wilmington 94
Redwood City 91
Woodbridge 88
Medford 87
Columbus 83
Princeton 79
Villeurbanne 74
Seattle 59
Dearborn 58
Cambridge 48
Turin 43
Boston 42
Jacksonville 38
Dong Ket 37
Boardman 30
Hangzhou 30
Pisa 28
Brussels 27
New York 27
Fremont 26
Milan 24
Guangzhou 23
Helsinki 23
Shanghai 22
Warsaw 22
Jakarta 21
Seoul 21
Nanjing 19
Chengdu 18
Tokyo 18
Madrid 17
Norwalk 14
Ottawa 14
Hebei 13
Los Angeles 13
Washington 13
Munich 12
São Paulo 12
Xian 12
Central District 11
Hefei 10
Wuhan 10
Dallas 9
London 9
Rome 9
Taipei 9
Toronto 9
Amsterdam 8
Barcelona 8
Fort Worth 8
Hong Kong 8
Mumbai 8
Riverton 8
San Diego 8
Aracaju 7
Chicago 7
Falls Church 7
Jinan 7
Silver Spring 7
Sydney 7
Verona 7
Buenos Aires 6
Medellín 6
Bethesda 5
Bologna 5
Bricherasio 5
Chongqing 5
Duncan 5
Hamburg 5
Hiroshima 5
Istanbul 5
Melbourne 5
Rochester 5
Vancouver 5
Xi'an 5
Zhengzhou 5
Ahmedabad 4
Atlanta 4
Bucharest 4
Düsseldorf 4
Edinburgh 4
Gent 4
Groslay 4
Nanchang 4
Napoli 4
New Delhi 4
Nuremberg 4
Orio Canavese 4
Totale 4.357
Salva come PNG Salva come JPEG
Nome #
Impulse control behaviors and subthalamic deep brain stimulation in Parkinson disease 662
Levodopa-carbidopa intestinal gel infusion and weight loss in Parkinson's disease 392
Progranulin expression in brain tissue and cerebrospinal fluidlevels in multiple sclerosis 368
Subthalamic deep brain stimulation: clinical and neuropsychological outcomes in mild cognitive impaired parkinsonian patients. 336
Atypical hereditary spastic paraplegia mimicking multiple sclerosis associated with a novel SPG11 mutation. 279
Does intraoperative microrecording really increase the risk of hemorrhagic complications in deep brain stimulation? 217
Beyond 35 years of Parkinson’s disease: a comprehensive clinical and instrumental assessment 138
Reverse blood pressure dipping as marker of dysautonomia in Parkinson disease 127
Neurological comorbidity and severity of COVID-19 113
What Happens When I Watch a Ballet and I Am Dyskinetic? A fMRI Case Report in Parkinson Disease. 108
Pure autonomic failure versus prodromal dysautonomia in Parkinson’s disease: Insights from the bedside 97
Blood pressure circadian rhythm alterations in alpha-synucleinopathies 97
Role of the cingulate cortex in dyskinesias-reduced-self-awareness: An fMRI study on Parkinson's disease patients 95
Cardiac organ damage in patients with Parkinson's disease and reverse dipping 90
Trait impulsivity and response-inhibition in Parkinson Disease. An fMRI study. 89
CIDP-like neuropathies in graft versus host disease 87
Cardiovascular autonomic neuropathy and falls in Parkinson disease: a prospective cohort study 86
Advanced therapies in Parkinson's disease: Long-term retrospective study 84
Benign versus malignant Parkinson disease: the unexpected silver lining of motor complications 83
Verbal communication about drug dosage balances drug reduction in Parkinson's disease: Behavioral and electrophysiological evidences 79
Transdermal rotigotine in dihydropteridine reductase deficiency 78
Pisa syndrome in Parkinson's disease is associated with specific cognitive alterations 78
Subcutaneous immunoglobulin in CIDP and MMN: a different long-term clinical response? 77
Earlier versus later subthalamic deep brain stimulation in Parkinson's disease 76
Detection of orthostatic hypotension with ambulatory blood pressure monitoring in parkinson’s disease 76
Deep brain stimulation in uncommon tremor disorders: indications, targets, and programming 75
Neurodegeneration and iron accumulation in deep grey matter nuclei in multiple sclerosis. 74
Orthostatic hypotension in Parkinson's disease: Does it matter if asymptomatic? 73
Deep brain stimulation fine-tuning in Parkinson's disease: Short pulse width effect on speech 73
Peripheral neuropathy associated with levodopa-carbidopa intestinal infusion: A long-term prospective assessment 72
Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study 72
Orthostatic hypotension in Parkinson disease: Impact on health care utilization 71
Subcutaneous vs. intravenous immunoglobulin in CIDP: pharmacokinetic and clinical response 70
Autonomic dysfunction in Parkinson's disease: A prospective cohort study 70
Long-term effect of levodopa-carbidopa intestinal gel on axial signs in Parkinson’s disease 68
Is lowering stimulation frequency a feasible option for subthalamic deep brain stimulation in Parkinson's disease patients with dysarthria? 67
Should We Consider Deep Brain Stimulation Discontinuation in Late-Stage Parkinson’s Disease? 67
COVID-19 and Parkinson's Disease: What We Know So Far? 67
Anxiety, depression, and worries in advanced Parkinson disease during COVID-19 pandemic 66
Peripheral Nerve Ultrasonography in Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy: Correlations with Clinical and Neurophysiological Data 63
A polysomnographic study in parkinsonian patients treated with intestinal levodopa infusion 63
Parkinsonism–hyperpyrexia syndrome and deep brain stimulation 63
Levodopa/Carbidopa Intestinal Gel Long-Term Outcome in Parkinson's Disease: Focus on Dyskinesia 61
Differential response to pallidal deep brain stimulation among monogenic dystonias: Systematic review and meta-analysis 60
Effects of intestinal Levodopa infusion on freezing of gait in Parkinson disease 60
Motor and non-motor outcomes of subthalamic deep brain stimulation in a case of juvenile PARK-PINK1 60
A new index to assess turning quality and postural stability in patients with Parkinson's disease 59
Involvement of the choroid plexus in multiple sclerosis autoimmune inflammation: A neuropathological study 58
Home monitoring of motor fluctuations in Parkinson’s disease patients 58
Association between sleep disorders and cognitive dysfunctions in non-demented patients with advanced Parkinson’s disease 58
Deep brain stimulation outcomes in the malignant end of Parkinson's disease spectrum 57
Machine learning applied to ambulatory blood pressure monitoring: a new tool to diagnose autonomic failure? 56
Current Directions in Deep Brain Stimulation for Parkinson’s Disease—Directing Current to Maximize Clinical Benefit 55
Efficacy of safinamide as add-on therapy after subthalamic nucleus deep brain stimulation in Parkinson disease 55
Association of Subthalamic Deep Brain Stimulation With Motor, Functional, and Pharmacologic Outcomes in Patients With Monogenic Parkinson Disease: A Systematic Review and Meta-analysis 54
Tuning Deep Brain Stimulation related depression by frequency modulation: a case report 54
Low frequency subthalamic stimulation and event-related potentials in Parkinson disease 54
COVID-19 in Parkinson's disease: Report on prevalence and outcome 53
Telemedicine in Neurological Disorders: Opportunities and Challenges 52
Onset of Covid-19 with impaired consciousness and ataxia: a case report 50
Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials 50
Peripheral neuropathy as marker of severe Parkinson's disease phenotype 49
Video analysis of long-term effects of levodopa-carbidopa intestinal gel on gait and posture in advanced Parkinson’s disease 49
Subcutaneous "bolus" immunoglobulin dose in CIDP: A proof-of concept study 48
Prevalence and burden of dysautonomia in advanced Parkinson's disease 47
Focal seizures with impaired awareness as long-term neurological complication of COVID-19: a case report 47
Association of Orthostatic Hypotension With Cerebral Atrophy in Patients With Lewy Body Disorders 47
Early reversible leukoencephalopathy and unilateral sixth cranial nerve palsy in mild COVID-19 infection 47
Preliminary evidence from a Line-Bisection Task for visuospatial neglect in Parkinson's disease 45
Orthostatic hypotension and REM sleep behaviour disorder: Impact on clinical outcomes in α-synucleinopathies 45
Levodopa-Induced Dyskinesias and Dyskinesias-Reduced-Self-Awareness in Parkinson’s Disease: A Neurocognitive Approach 45
Neurological comorbidities and COVID-19-related case fatality: A cohort study 45
Effect of subthalamic deep brain stimulation on posture in Parkinson's disease: A blind computerized analysis 44
Levodopa and neuropathy risk in patients with Parkinson disease: Effect of COMT inhibition 43
Functional neurological disorders in Parkinson disease 40
Subthalamic deep brain stimulation and trunk posture in Parkinson's disease 38
Levodopa-Induced Neuropathy: A Systematic Review 36
Levodopa-Induced Dyskinesias and Dyskinesias-Reduced-Self-Awareness in Parkinson’s Disease: A Neurocognitive Approach 31
Differential impact of individual autonomic domains on clinical outcomes in Parkinson's disease 30
Effects of dopaminergic therapy on sleep quality in fluctuating Parkinson’s disease patients 29
Multiple sclerosis relapses: a multivariable analysis of residual disability determinants 28
SARS-CoV-2 vaccination, Parkinson's disease, and other movement disorders: case series and short literature review 26
Burden of caregiving for cardiovascular dysautonomia in Parkinson's disease 26
Reply to: "Autonomic dysfunction in Parkinson's disease: The hidden game changer?" 25
15-Year Subthalamic Deep Brain Stimulation outcome in a Parkinson’s disease patient with Parkin gene mutation: a case report 22
How resistant are levodopa-resistant axial symptoms? Response of freezing, posture, and voice to increasing levodopa intestinal infusion rates in Parkinson disease 19
Hypotensive episodes at 24-h ambulatory blood pressure monitoring predict adverse outcomes in Parkinson’s disease 15
Deep Brain Stimulation Outcomes in Parkinson's Disease Patients with Cognitive Impairment: Implications and Considerations 14
Incidence and predictors of postural abnormalities in Parkinson's disease: a PPMI cohort study 11
Levodopa-carbidopa intestinal gel infusion (LCIG) in Parkinson disease with genetic mutations 10
Neurological symptoms in adults with Gaucher disease: a systematic review 9
Effects of Continuous Dopaminergic Stimulation on Parkinson's Disease Gait: A Longitudinal Prospective Study with Levodopa Intestinal Gel Infusion 9
Axial symptoms as main predictors of short-term subthalamic stimulation outcome in Parkinson's disease 8
NoMoFa as a new tool to evaluate the impact of deep brain stimulation on non-motor fluctuations: A new perspective 5
Totale 7.282
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.570
article - articoli 0
book - libri 0
conference - conferenze 477
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.047
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020642 0 0 0 0 71 83 98 77 80 90 66 77
2020/2021820 61 121 82 47 66 55 47 59 66 65 54 97
2021/20221.056 56 35 47 111 61 49 51 50 47 85 262 202
2022/20231.590 166 173 51 173 154 391 90 89 164 35 70 34
2023/2024756 111 129 42 28 76 96 26 46 4 57 41 100
2024/2025768 31 105 62 194 376 0 0 0 0 0 0 0
Totale 7.282